Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

KRASG12C inhibition: A major landmark in 2nd line treatment of patients with advanced NSCLC (ID 327)

Lecture Time
11:35 - 11:50
Speakers
  • Joop De Langen, Amsterdam, NL
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00